Peer Review reports
From: Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
| Original Submission | ||
|---|---|---|
| 16 Jan 2024 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 1 Mar 2024 | Author responded | Author comments - Joon Oh Park |
| Resubmission - Version 4 | ||
| 1 Mar 2024 | Submitted | Manuscript version 4 |
| 31 Mar 2024 | Reviewed | Reviewer Report |
| 9 May 2024 | Reviewed | Reviewer Report - Takaaki Mizuno |
| 27 Jun 2024 | Author responded | Author comments - Joon Oh Park |
| Resubmission - Version 5 | ||
| 27 Jun 2024 | Submitted | Manuscript version 5 |
| Publishing | ||
| 1 Jul 2024 | Editorially accepted | |
| 13 Aug 2024 | Article published | 10.1186/s12885-024-12584-0 |
You can find further information about peer review here.